Literature DB >> 23145206

Tumor-associated macrophages: function, phenotype, and link to prognosis in human lung cancer.

Jon G Quatromoni1, Evgeniy Eruslanov.   

Abstract

Macrophages are the dominant leukocyte population found in the tumor microenvironment. Accumulating evidence suggests that these tumor-associated macrophages (TAMs) actively promote all aspects of tumor initiation, growth, and development. However, TAMs are not a single uniform population; instead, they are composed of multiple distinct pro- and anti-tumoral subpopulations with overlapping features depending on a variety of external factors. Defining and differentiating these subsets remains a challenging work-in-progress. These difficulties are apparent in prognostic studies in lung cancer that initially demonstrated conflicting evidence regarding the significance of TAMs but which have more recently clarified and confirmed the clinical importance of these subsets through improved phenotypic capabilities. Thus, these cells represent potential targets for cancer therapeutic initiatives through translational approaches. In this review, we summarize the current understanding of how the tumor microenvironment takes advantage of macrophage plasticity to mold an immunosuppressive population, the phenotypic heterogeneity of TAMs, and their link to prognosis in human lung cancer.

Entities:  

Keywords:  Myeloid cells; lung cancer; phenotype; prognosis; tumor microenvironment; tumor-associated macrophages

Year:  2012        PMID: 23145206      PMCID: PMC3493031     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  97 in total

1.  Macrophage galactose-type C-type lectins as novel markers for alternatively activated macrophages elicited by parasitic infections and allergic airway inflammation.

Authors:  Geert Raes; Lea Brys; Bhola K Dahal; Jef Brandt; Johan Grooten; Frank Brombacher; Guido Vanham; Wim Noël; Pieter Bogaert; Tom Boonefaes; Anne Kindt; Rafaël Van den Bergh; Pieter J M Leenen; Patrick De Baetselier; Gholamreza Hassanzadeh Ghassabeh
Journal:  J Leukoc Biol       Date:  2004-12-09       Impact factor: 4.962

Review 2.  Cancer-related inflammation: common themes and therapeutic opportunities.

Authors:  Frances R Balkwill; Alberto Mantovani
Journal:  Semin Cancer Biol       Date:  2011-12-24       Impact factor: 15.707

3.  Stromal macrophage expressing CD204 is associated with tumor aggressiveness in lung adenocarcinoma.

Authors:  Yoichi Ohtaki; Genichiro Ishii; Kanji Nagai; Satoshi Ashimine; Takeshi Kuwata; Tomoyuki Hishida; Mitsuyo Nishimura; Junji Yoshida; Izumi Takeyoshi; Atsushi Ochiai
Journal:  J Thorac Oncol       Date:  2010-10       Impact factor: 15.609

4.  Gene expression analysis of macrophages that facilitate tumor invasion supports a role for Wnt-signaling in mediating their activity in primary mammary tumors.

Authors:  Laureen S Ojalvo; Charles A Whittaker; John S Condeelis; Jeffrey W Pollard
Journal:  J Immunol       Date:  2009-12-16       Impact factor: 5.422

5.  Up-regulation of tumor interleukin-8 expression by infiltrating macrophages: its correlation with tumor angiogenesis and patient survival in non-small cell lung cancer.

Authors:  Jeremy J W Chen; Pei-Li Yao; Ang Yuan; Tse-Ming Hong; Chia-Tung Shun; Min-Liang Kuo; Yung-Chie Lee; Pan-Chyr Yang
Journal:  Clin Cancer Res       Date:  2003-02       Impact factor: 12.531

6.  Predominant infiltration of macrophages and CD8(+) T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer.

Authors:  Osamu Kawai; Genichiro Ishii; Kaoru Kubota; Yukinori Murata; Yoichi Naito; Tetsuya Mizuno; Keiju Aokage; Nagahiro Saijo; Yutaka Nishiwaki; Akihiko Gemma; Syoji Kudoh; Atsushi Ochiai
Journal:  Cancer       Date:  2008-09-15       Impact factor: 6.860

7.  The number and microlocalization of tumor-associated immune cells are associated with patient's survival time in non-small cell lung cancer.

Authors:  Fuqiang Dai; Lunxu Liu; Guowei Che; Nanbin Yu; Qiang Pu; Shangfu Zhang; Junliang Ma; Lin Ma; Zongbing You
Journal:  BMC Cancer       Date:  2010-05-20       Impact factor: 4.430

8.  TREM-1 expression in tumor-associated macrophages and clinical outcome in lung cancer.

Authors:  Chao-Chi Ho; Wei-Yu Liao; Cheng-Yi Wang; Yin-Hsiu Lu; Hsin-Yi Huang; Hsuan-Yu Chen; Wing-Kai Chan; Huei-Wen Chen; Pan-Chyr Yang
Journal:  Am J Respir Crit Care Med       Date:  2007-12-20       Impact factor: 21.405

Review 9.  Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy.

Authors:  Antonio Sica; Tiziana Schioppa; Alberto Mantovani; Paola Allavena
Journal:  Eur J Cancer       Date:  2006-03-07       Impact factor: 9.162

10.  Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy.

Authors:  E Y Lin; A V Nguyen; R G Russell; J W Pollard
Journal:  J Exp Med       Date:  2001-03-19       Impact factor: 14.307

View more
  161 in total

1.  Acute myeloid leukemia cells polarize macrophages towards a leukemia supporting state in a Growth factor independence 1 dependent manner.

Authors:  Yahya S Al-Matary; Lacramioara Botezatu; Bertram Opalka; Judith M Hönes; Robert F Lams; Aniththa Thivakaran; Judith Schütte; Renata Köster; Klaus Lennartz; Thomas Schroeder; Rainer Haas; Ulrich Dührsen; Cyrus Khandanpour
Journal:  Haematologica       Date:  2016-07-07       Impact factor: 9.941

2.  Characterization of M1/M2 Tumour-Associated Macrophages (TAMs) and Th1/Th2 Cytokine Profiles in Patients with NSCLC.

Authors:  S A Almatroodi; C F McDonald; I A Darby; D S Pouniotis
Journal:  Cancer Microenviron       Date:  2015-08-30

Review 3.  Microbiome, bile acids, and obesity: How microbially modified metabolites shape anti-tumor immunity.

Authors:  Laura M Sipe; Mehdi Chaib; Ajeeth K Pingili; Joseph F Pierre; Liza Makowski
Journal:  Immunol Rev       Date:  2020-05       Impact factor: 12.988

4.  IL17A Regulates Tumor Latency and Metastasis in Lung Adeno and Squamous SQ.2b and AD.1 Cancer.

Authors:  Ran You; Francesco J DeMayo; Jian Liu; Sung-Nam Cho; Bryan M Burt; Chad J Creighton; Roberto F Casal; Donald R Lazarus; Wen Lu; Hui-Ying Tung; Xiaoyi Yuan; Andrea Hill-McAlester; Myunghoo Kim; Sarah Perusich; Loraine Cornwell; Daniel Rosen; Li-Zhen Song; Silke Paust; Gretchen Diehl; David Corry; Farrah Kheradmand
Journal:  Cancer Immunol Res       Date:  2018-04-13       Impact factor: 11.151

5.  Angiogenic capacity of M1- and M2-polarized macrophages is determined by the levels of TIMP-1 complexed with their secreted proMMP-9.

Authors:  Ewa Zajac; Bernhard Schweighofer; Tatyana A Kupriyanova; Anna Juncker-Jensen; Petra Minder; James P Quigley; Elena I Deryugina
Journal:  Blood       Date:  2013-10-30       Impact factor: 22.113

6.  M2 tumor-associated macrophages play important role in predicting response to neoadjuvant chemotherapy in triple-negative breast carcinoma.

Authors:  Vidya Arole; Hiroaki Nitta; Lai Wei; Tiansheng Shen; Anil V Parwani; Zaibo Li
Journal:  Breast Cancer Res Treat       Date:  2021-05-25       Impact factor: 4.872

Review 7.  Innate and adaptive immune cells in the tumor microenvironment.

Authors:  Thomas F Gajewski; Hans Schreiber; Yang-Xin Fu
Journal:  Nat Immunol       Date:  2013-10       Impact factor: 25.606

Review 8.  Radiation and inflammation.

Authors:  Dörthe Schaue; Ewa D Micewicz; Josephine A Ratikan; Michael W Xie; Genhong Cheng; William H McBride
Journal:  Semin Radiat Oncol       Date:  2015-01       Impact factor: 5.934

9.  27-Hydroxycholesterol acts on myeloid immune cells to induce T cell dysfunction, promoting breast cancer progression.

Authors:  Liqian Ma; Lawrence Wang; Adam T Nelson; Chaeyeon Han; Sisi He; Madeline A Henn; Karan Menon; Joy J Chen; Amy E Baek; Anna Vardanyan; Sayyed Hamed Shahoei; Sunghee Park; David J Shapiro; Som G Nanjappa; Erik R Nelson
Journal:  Cancer Lett       Date:  2020-08-28       Impact factor: 8.679

Review 10.  Circulating tumor cell interactions with macrophages: implications for biology and treatment.

Authors:  Gerhard Hamilton; Barbara Rath
Journal:  Transl Lung Cancer Res       Date:  2017-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.